Tilray Brands (TLRY) EBT Margin Growth (1y) (2018 - 2026)
Tilray Brands (TLRY) EBT Margin Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 342.00 |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -166.00 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -5,404.00 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -1,258.00 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 8,812.00 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 2,773.00 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 132.00 |
| 10 | Tilray Brands | 465.02 Mn | 373.06 Mn | 54.95 Mn | 41,524.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 41,524.00 |
| Nov 30, 2025 | 2,109.00 |
| Aug 31, 2025 | 1,651.00 |
| May 31, 2025 | -65,490.00 |
| Feb 28, 2025 | -36,922.00 |
| Nov 30, 2024 | -1,388.00 |
| Aug 31, 2024 | 1,059.00 |
| May 31, 2024 | -41,696.00 |
| Feb 29, 2024 | 77,148.00 |
| Nov 30, 2023 | 2,531.00 |
| Aug 31, 2023 | 1,077.00 |
| May 31, 2023 | 61,752.00 |
| Feb 28, 2023 | -86,209.00 |
| Nov 30, 2022 | -5,097.00 |
| Aug 31, 2022 | -2,048.00 |
| May 31, 2022 | -43,009.00 |
| Feb 28, 2022 | 23,701.00 |
| Nov 30, 2021 | 7,998.00 |
| Aug 31, 2021 | 570.00 |
| May 31, 2021 | 24,933.00 |